Consider semaglutide if: You prioritize lower cost and established safety data You have a history of GI sensitivity and prefer gradual titration You want to start with the more affordable option (semaglutide at $299/month) You're seeking 15-18% weight loss with solid cardiovascular benefit Consider tirzepatide if: You have more aggressive weight loss goals (20%+ reduction) You have type 2 diabetes or significant cardiometabolic risk Cost is not a primary barrier You tolerate GI side effects well or are willing to manage them Many patients find success on either medication
These medications, including Tirzepatide as a prime example, are thoroughly researched and FDA-approved, ensuring their safety and efficacy when used under medical supervision
Sermorelin is generally well-tolerated, but some users may experience mild side effects, primarily due to its stimulation of growth hormone release
Yes, particularly if there is a blockage or bloating
(Ozempic is also approved to reduce cardiovascular and kidney-related risks in people with diabetes.) Is it safe to take a GLP-1 while breastfeeding
Incorporating Wegovy into your weight management plan could be a path toward liberating yourself from obesity
